Engaging communities in tuberculosis research

…, L Pyne-Mercier, SD Williams, LR Mingote… - The Lancet infectious …, 2013 - thelancet.com
According to a growing consensus among biomedical researchers, community engagement
can improve the ethics and outcomes of clinical trials. Although successful efforts to develop …

The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities

LR Mingote, D Namutamba, F Apina, N Barnabas… - The Lancet, 2015 - thelancet.com
… The Viewpoint by Laia Ruiz Mingote and colleagues 1 raises safety concerns regarding
bedaquiline in treatment shortening trials for pan-resistant tuberculosis (tuberculosis that is …

[HTML][HTML] How ethical is your clinical trial?

…, B Nkala, LM Kasirye, LR Mingote… - … journal of clinical …, 2010 - ncbi.nlm.nih.gov
Is Institutional Review Board (IRB) approval and a rigorous informed consent process enough?
It is our view that this is no longer the case. Conventional research ethics emphasise the …

The evolving role of advocacy in tuberculosis

…, E Lessem, D Wegener, LR Mingote… - The Lancet …, 2014 - thelancet.com
Tuberculosis advocacy has changed the disease from a silent epidemic to one with many
voices that seek increased political will and investment in research. 1 Tuberculosis advocacy …

Developing a framework for evaluating ethical outcomes of good participatory practices in TB clinical drug trials

…, NT Eley, M Frick, LR Mingote… - Journal of Empirical …, 2016 - journals.sagepub.com
Laia Ruiz Mingote is a journalist by training who has devoted her professional career to the
promotion of human rights; she is a strong advocate of the inclusion of affected communities …

Paediatric study of bedaquiline remains an “open issue”

L McKenna, LR Mingote - European Respiratory Journal, 2016 - Eur Respiratory Soc
In their editorial, “Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical
analysis of the evidence”, Pontali et al. [1] detail and analyse the existing evidence for …

[HTML][HTML] Informed use of bedaquiline for tuberculosis–Authors' reply

LR Mingote, D Namutamba, B Seaworth, C Lee… - The Lancet, 2015 - thelancet.com
We thank Erica Lessem and colleagues for commenting on our Viewpoint 1 regarding the
challenges surrounding the bedaquiline patient registry in the USA. For drugs like bedaquiline …

[HTML][HTML] Real engagement with communities

LR Mingote, W Vandevelde, B Kumar… - The Lancet Respiratory …, 2015 - thelancet.com
In an editorial, 1 The Lancet Respiratory Medicine expresses the general thinking in the
tuberculosis discipline that a bold approach is needed to eliminate this deadly but curable …

Informed use of bedaquiline for tuberculosis

J Furin - The Lancet, 2015 - thelancet.com
… The Viewpoint by Laia Ruiz Mingote and colleagues1 raises safety concerns regarding
bedaquiline in treatment shortening trials for pan-resistant tuberculosis (tuberculosis that is …

Risk factors for and origins of COPD

AL Byrne, BJ Marais, CD Mitnick, L Lecca, GB Marks - The Lancet, 2015 - thelancet.com
… The Viewpoint by Laia Ruiz Mingote and colleagues1 raises safety concerns regarding
bedaquiline in treatment shortening trials for pan-resistant tuberculosis (tuberculosis that is …